Drugs to combat HIV are about to become cheaper in developing countries. The
multinationals Glaxo Wellcome and Hoffmann-La Roche will supply drugs at cut
rates to Uganda, Côte d’Ivoire, Chile and Vietnam in a two-year pilot
initiative organised by the Joint UN Programme on HIV/AIDS. Virco, a Belgian
diagnostics company, will train local technicians to screen patients to work out
which drugs to use. “We want to demonstrate that it is workable and
sustainable,” says Joseph Saba, the initiative’s coordinator. The extent of the
discounts is still being worked out.
More from New Scientist
Explore the latest news, articles and features
Environment
Galapagos corals suggest climate change drives stronger El Niños
News
Life
Astonishing whale feeding frenzy seen off the eastern coast of Greenland
News
Environment
Octopuses released into Adriatic Sea to tackle invasive crabs
News
Technology
Driving data can predict crash black spots before accidents happen
News
Popular articles
Trending New Scientist articles